Tower Research Capital (TRC)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,367
Closed -$1.72M 6635
2021
Q2
$1.72M Sell
9,367
-19,194
-67% -$3.53M 0.04% 366
2021
Q1
$4.37M Buy
28,561
+23,615
+477% +$3.61M 0.07% 244
2020
Q4
$773K Sell
4,946
-4,716
-49% -$737K 0.02% 669
2020
Q3
$1.11M Buy
9,662
+2,791
+41% +$319K 0.01% 896
2020
Q2
$772K Buy
6,871
+5,992
+682% +$673K 0.03% 690
2020
Q1
$79K Sell
879
-905
-51% -$81.3K ﹤0.01% 1088
2019
Q4
$193K Sell
1,784
-2,094
-54% -$227K 0.02% 606
2019
Q3
$380K Buy
3,878
+1,875
+94% +$184K 0.03% 692
2019
Q2
$263K Sell
2,003
-2,017
-50% -$265K 0.02% 742
2019
Q1
$543K Buy
4,020
+3,721
+1,244% +$503K 0.03% 553
2018
Q4
$29K Buy
+299
New +$29K ﹤0.01% 1663
2018
Q3
Sell
-12,315
Closed -$1.53M 4449
2018
Q2
$1.53M Buy
12,315
+11,984
+3,621% +$1.49M 0.09% 219
2018
Q1
$37K Buy
331
+272
+461% +$30.4K ﹤0.01% 1857
2017
Q4
$7K Buy
+59
New +$7K ﹤0.01% 2775
2017
Q3
Sell
-1,793
Closed -$218K 4397
2017
Q2
$218K Buy
1,793
+1,761
+5,503% +$214K 0.02% 324
2017
Q1
$4K Sell
32
-1,397
-98% -$175K ﹤0.01% 2386
2016
Q4
$175K Buy
+1,429
New +$175K 0.02% 686
2016
Q3
Sell
-203
Closed -$24K 4790
2016
Q2
$24K Sell
203
-280
-58% -$33.1K ﹤0.01% 2103
2016
Q1
$67K Buy
483
+343
+245% +$47.6K 0.01% 645
2015
Q4
$27K Sell
140
-1,060
-88% -$204K ﹤0.01% 998
2015
Q3
$188K Buy
+1,200
New +$188K 0.02% 302
2015
Q2
Sell
-871
Closed -$151K 5311
2015
Q1
$151K Buy
+871
New +$151K 0.02% 582
2014
Q4
Sell
-1,978
Closed -$328K 4967
2014
Q3
$328K Buy
+1,978
New +$328K 0.04% 354
2014
Q2
Sell
-325
Closed -$49K 4895
2014
Q1
$49K Sell
325
-329
-50% -$49.6K 0.01% 1111
2013
Q4
$87K Buy
654
+321
+96% +$42.7K 0.01% 945
2013
Q3
$38K Sell
333
-52
-14% -$5.93K ﹤0.01% 2167
2013
Q2
$36K Buy
+385
New +$36K ﹤0.01% 1196